<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37127567</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1476-4954</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians</Title><ISOAbbreviation>J Matern Fetal Neonatal Med</ISOAbbreviation></Journal><ArticleTitle>Pregnancy outcomes in systemic lupus erythematosus: experience from a Caribbean center.</ArticleTitle><Pagination><StartPage>2204392</StartPage><MedlinePgn>2204392</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/14767058.2023.2204392</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Systemic Lupus Erythematosus (SLE) is a chronic autoimmune multi-system disorder frequently affecting black women of childbearing age. No published data exist on the obstetric outcomes in a Caribbean population.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">We analyzed pregnancy outcomes in an Afro-Caribbean cohort of women with SLE at a tertiary university hospital.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A retrospective cohort study was performed of all pregnant women with SLE prior to pregnancy from January 1990 to December 2021 at the University Hospital of the West Indies (UHWI), Jamaica. Maternal rheumatologic, obstetric, fetal/neonatal data were analyzed. Descriptive statistical analyses were performed. To determine if outcomes were associated with various factors, Spearman's rho was followed by logistic regression analysis to estimate unadjusted odds ratios with statistical significance at <i>p</i>&#x2009;&lt;&#x2009;0.05.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 56 pregnancies in 47 women were identified with SLE. Live births were 87.5%, with 10.7% spontaneous miscarriages and no neonatal deaths. Prednisone was the most used drug in 67.9% of patients. 85% of women had an adverse outcome with an adverse fetal outcome occurring in 55% of cases. Prednisone was associated with an adverse fetal/neonatal outcome (Spearman's rho = 0.38; <i>p</i>&#x2009;=&#x2009;.004).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In this first Caribbean series on SLE in pregnancy, reasonably successful pregnancy outcomes are achievable in Afro-Caribbean women managed in multidisciplinary centers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gibson</LastName><ForeName>Shanea</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6593-7852</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, University of the West Indies, Mona, Kingston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2337-1520</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, University of the West Indies, Mona, Kingston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson Brown</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, University of the West Indies, Mona, Kingston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartley</LastName><ForeName>Shwantay</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6165-0192</Identifier><AffiliationInfo><Affiliation>Department of Basic Medical Sciences, University of the West Indies, Mona, Kingston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maloney</LastName><ForeName>Keisha</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of the West Indies, Mona, Kingston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gossell-Williams</LastName><ForeName>Maxine</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4268-5960</Identifier><AffiliationInfo><Affiliation>Department of Basic Medical Sciences, University of the West Indies, Mona, Kingston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunter</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7922-0345</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, University of the West Indies, Mona, Kingston.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Matern Fetal Neonatal Med</MedlineTA><NlmUniqueID>101136916</NlmUniqueID><ISSNLinking>1476-4954</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>VB0R961HZT</RegistryNumber><NameOfSubstance UI="D011241">Prednisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011241" MajorTopicYN="N">Prednisone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011248" MajorTopicYN="Y">Pregnancy Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014900" MajorTopicYN="N" Type="Geographic">West Indies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017691" MajorTopicYN="N" Type="Geographic">Caribbean Region</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Caribbean</Keyword><Keyword MajorTopicYN="N">Systemic lupus</Keyword><Keyword MajorTopicYN="N">auto-immune</Keyword><Keyword MajorTopicYN="N">pregnancy outcomes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37127567</ArticleId><ArticleId IdType="doi">10.1080/14767058.2023.2204392</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>